Scienture Holdings, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SCNX | SCLX | PHRM.CN | SILO | 18H0.F | CVKD | |
|---|---|---|---|---|---|---|
| Market cap | 5.62M | 12.87M | 4.55M | 2.93M | 5.11M | 3.78M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -12.7 | 2.5 | -0.5 | -1.9 | — | -0.3 |
| Price/book | 0.1 | 0.0 | 7.1 | 0.3 | -1.1 | 0.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −82.40% | −83.91% | −52.38% | −82.01% | −38.46% | −91.14% |
| Today | −0.87% | −1.08% | −16.67% | +3.91% | −23.81% | −6.19% |
The closest companies by business and industry (Pharmaceutical Retailers). Prices may be delayed up to 15 min.
Latest news
All SCNX news ›SCI Engineered Materials, Inc. Reports 2026 Third Quarter and Year-to-Date Results
COLUMBUS, OH / ACCESS Newswire / October 29, 2026 / SCI Engineered Materials, Inc. (SCIA), today reported financial results for the three months and nine months ended September 30, 2026. The Company's third quarter of 2026 gross profit…
Scienture Holdings, Inc. (SCNX) Shareholder/Analyst Call Prepared Remarks Transcript
Scienture Holdings, Inc. (SCNX) Shareholder/Analyst Call October 28, 2026 11:00 AM EDT Shankar Hariharan - Founder, Co-CEO & Executive Chairman Louis Kern - Dykema Gossett PLLC Welcome to the Virtual 2026 Annual Meeting of Stockholders of…
Scienture Holdings, Inc. (NASDAQ:SCNX) Sees Large Decrease in Short Interest
Scienture Holdings, Inc. (NASDAQ:SCNX – Get Free Report) was the recipient of a large decline in short interest in October. As of October 15th, there was short interest totaling 105,863 shares, a decline of 91.9% from the September 30th…
Scimplify is profitable & targeting 2.5x revenue growth. What’s driving its next phase of expansion?
Scimplify has turned profitable and is targeting 2.5 times its cumulative revenue since inception this financial year. The Bengaluru-based advanced materials startup, which recently raised $25 million from Hitachi Ventures-led investors,…
Scienture Reports Preliminary Q3 Revenue of $1.22 Million, Up 256%
Scienture Holdings, Inc. (SCNX) reported preliminary, unaudited revenue of approximately $1.22 million for the third quarter ended September 30, 2026, up 256% from approximately $344,000 in the second quarter.The company attributed the…
Scienture Holdings reports preliminary Q3 results
Scienture (SCNX) reports preliminary Q3 unaudited revenue of ~$1.22M (+256% QoQ), driven by REZENOPY launch and Arbli unit growth. - Scienture Holdings, Inc. press release (SCNX): Q3 preliminary unaudited revenue of approximately $1.22M,…
Contrasting Scienture (NASDAQ:SCNX) & Gyre Therapeutics (NASDAQ:GYRE)
Posted by Mitch Edgeman on Oct 13th, 2026 Scienture (NASDAQ:SCNX – Get Free Report) and Gyre Therapeutics (NASDAQ:GYRE – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com4
- themarketsdaily.com2
- cnbctv18.com1
- quiverquant.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.